Tuberculosis ulcerosa mucosae et cutis
Last Updated: 2019-08-26
ICD11: -
Last Updated: 2019-08-26
Author(s): Anzengruber F., Navarini A.
ICD11: -
Tuberculosis orificialis.
Tuberculous infestation of the mucous membranes occurring with pronounced immunosuppression.
Men from the middle age are preferably afflicted.
The disease occurs when the immunity situation is unfavourable.
The term infectious tuberculosis refers to the infection of the sites through which secretions rich in tubercle bacteria are excreted (anus, rectum, kidney, lung).
Enoral (from larynx to lips) and perioral dolent, ulcerating papules and pustules.
CAVE: The contact density is particularly high due to the high number of tubercle bacteria in the skin lesions.
Clinic.
The tuberculin test is often false negative (due to the usually poor immune situation).
To exclude system involvement:
Sonography of the abdomen and kidneys.
In the morning (fasting up to 4h) on 3 consecutive days sputum must be collected.
In the morning on 3 consecutive days urine must be given (fluid restriction the evening before!).
Bronchoalveolar lavage (BAL).
Non-specific, cellular proliferating, partly necrotizing inflammation, tuberculoid granulomas.
In most cases, disseminated organ infestation occurs.
Therapy schedule:
The initial phase should last 8 weeks/2 months. During this time, the majority of bacteria are killed. In the following therapy phase (which lasts for months), an attempt is made to eliminate the remaining bacteria. The antituberculous therapy should be continued for at least 2 months after the absence of skin symptoms.
Pyrazinamid p.o. 35 mg/ bw/ d if necessary combination with allopurinol!
Consolidation phase:
Rifampicin p.o. 10 mg/kg bw/ d
Isoniazid p.o. 5 mg/kg bw. (with Vit B 6)
Ethambutol p.o. 15 mg/kg bw/d (may be omitted if isoniazid resistance has been excluded)
HIV Patient: Therapy must be done at ≥ for 7 months. Ethambutol should be replaced by streptomycin p.o. 15-20 mg/kg bw/d (from > 60 years max 750 mg) in case of additional therapy with NNRTI.
· Lidocaine
Share your experience and shape the future with us!
Do you have 5 minutes to take our short survey?
Together with you we would like to further develop DermaCompass.
There is the chance to win one of 3x50 EUR Amazon vouchers.
Be part of our innovation process!
Share your experience